ArticleCancer research communications2022

Phase I Study of High-Dose L-methylfolate in Combination with Temozolomide and Bevacizumab in Recurrent IDH wild-type High-Grade Glioma.

Lucas A Salas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.